Disorders of Tetrahydrobiopterin Metabolism and their Treatment
Journal:
Current Drug Metabolism
Volume:
3
Page:
123-131
Author(s):
H. Shintaku
Nicotinic Agonists and Psychosis
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
149-162
Author(s):
J. K. Simosky, K. E. Stevens and R. Freedman
Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
215-225
Author(s):
Darryle D. Schoepp and Gerard J. Marek
Herpes Simplex Virus Vectors for the Nervous System
Journal:
Current Gene Therapy
Volume:
1
Page:
339-358
Author(s):
C. E. Lilley, R. H. Branston and R. S. Coffin
Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
225-238
Author(s):
J. Garcia de Yebenes and M. P. Sanchez
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
Development of Neurotrophic Molecules for Treatment of Neurode-generation
Journal:
Current Protein & Peptide Science
Volume:
2
Page:
261-276
Author(s):
Zhe-yu Chen, Li Cao, Li-mei Wang, Chao Guo, Jun-Li Ye, Yan-Feng Chai and Zhi-Yong Yan
Cytochromes P450 in Brain: Function and Significance
Journal:
Current Drug Metabolism
Volume:
2
Page:
199-214
Author(s):
H. W. Strobel, C. M. Thompson and L. Antonovic
Involvement of Tachykinins in Intestinal Inflammation
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
19-30
Author(s):
S. Evangelista
The Genetics of Frontotemporal Dementia and Related Disorders
Journal:
Current Genomics
Volume:
1
Page:
339-352
Author(s):
M. J. Sobrido, M. Wiedau-Pazos and D. H. Geschwind